lobbying_activities: 1736877

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1736877	8647783b-df86-440e-bab8-c7c2466a2583	Q3	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2015	third_quarter	PHA	Medicare Prescription Drug Act; HR 9, Innovation Act; 21st Century Cures Act; prescription drug costs; Trans Pacific Partnership (TPP) Agreement (provisions relating to data protection for biologics);and budget reconciliation legislation (provisions relating to healthcare).	HOUSE OF REPRESENTATIVES	40000		0	0	2015-10-18T21:31:16.157000-04:00